APA (7th ed.) Citation

Oh, J., Yi, S., Gu, N., Shin, D., Yu, K., Yoon, S. H., . . . Jang, I. Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity. BioMed Central.

Chicago Style (17th ed.) Citation

Oh, Jaeseong, Sojeong Yi, Namyi Gu, Dongseong Shin, Kyung-Sang Yu, Seo Hyun Yoon, Joo-Youn Cho, and In-Jin Jang. Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity. BioMed Central.

MLA (9th ed.) Citation

Oh, Jaeseong, et al. Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity. BioMed Central.